Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 11 |
| Receivables | 1,626 | 660 | 1,041 | 886 |
| Inventories | 356 | 93 | 95 | 95 |
| TOTAL | $2,126 | $803 | $1,205 | $1,045 |
| Non-Current Assets | ||||
| PPE Net | 302 | 306 | 309 | 310 |
| Intangibles | 3,736 | 2,099 | 2,091 | 1,984 |
| Other Non-Current Assets | 0 | 0 | 21 | 47 |
| TOTAL | $4,038 | $2,405 | $2,421 | $2,341 |
| Total Assets | $6,164 | $3,208 | $3,625 | $3,385 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 77 | 2,012 | 2,240 | 946 |
| Accounts payable and accrued liabilities | 2,731 | 2,612 | 2,596 | 1,559 |
| Accrued Expenses | N/A | 280 | 275 | 407 |
| TOTAL | $4,501 | $5,028 | $5,198 | $3,052 |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | N/A | 580 | 1,460 |
| Other Non-Current Liabilities | 301 | 306 | 236 | 241 |
| TOTAL | $301 | $306 | $816 | $1,701 |
| Total Liabilities | $4,802 | $5,334 | $6,014 | $4,753 |
| Shareholders' Equity | ||||
| Common Shares | 8,755 | 5,986 | 4,593 | 4,659 |
| Retained earnings | -8,321 | -8,230 | -7,090 | -6,101 |
| Other shareholders' equity | 433 | -266 | -192 | -192 |
| TOTAL | $1,362 | $-2,126 | $-2,389 | $-1,368 |
| Total Liabilities And Equity | $6,164 | $3,208 | $3,625 | $3,385 |